Nearly half of US COVID-19 cases now caused by JN.1 variant
Dec 28, 2023
The speed at which the JN.1 variant has spread this month suggests that it may spread more easily and be better at evading the immune system.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.
Physical activity inversely tied to COPD symptom burden
Nov 15, 2023
The findings were seen even in patients with mild or previously undiagnosed disease.
Coadministration of COVID-19, influenza vaccines seems effective
Nov 09, 2023
The researchers found that the incidence rates of emergency department or urgent care encounters and outpatient visits were slightly higher for the coadministration group versus the BNT162b2-biv-only group...
Paxlovid not helpful for reducing most post-COVID-19 conditions
Oct 31, 2023
No differences were seen in most post-COVID-19 conditions examined individually or by organ system, apart from a lower combined risk for venous thromboembolism and pulmonary embolism.
Differences seen in immune, hormone function for those with long COVID
Sep 29, 2023
Differences were identified in circulating myeloid and lymphocyte populations, as well as exaggerated humoral responses against SARS-CoV-2.
Just 23 percent of US adults ‘definitely’ plan to get new COVID-19 vaccine
Sep 27, 2023
Interest is highest among those aged 65 years and older (64%) and among Democrats (70%).
1.3 percent of children, 6.9 percent of adults ever had long COVID
Sep 26, 2023
Based on data from the 2022 National Health Interview Survey, 1.3% of children and 6.8% of adults have had long COVID.
Nirmatrelvir, molnupiravir use lowers risks for omicron-infected
Sep 25, 2023
Adjusted hazard ratios for hospitalization and death were reduced with both treatments.
Infection with omicron less likely to result in post-COVID-19 condition
Sep 18, 2023
No variation in the risk for post-COVID-19 condition was seen based on the number of vaccinations, but previous infection was linked to reduced post-COVID-19 condition risk.